HighTower Advisors, LLC

Position in PRME — Prime Medicine, Inc.

CIK 1462245 CHICAGO, IL

Position in PRME

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$1,255,946

+$71,859 QoQ

Shares Held

340,365

+0.0% QoQ

Ownership

0.188%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#37

of 186 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HighTower Advisors, LLC holds $312,855,129 across 115 Biotechnology names. PRME ranks #22 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INBX	Inhibrx Biosciences, Inc.	870,551	$82,484,707
2	REGN	Regeneron Pharmaceuticals, Inc.	64,650	$40,311,861
3	ALNY	Alnylam Pharmaceuticals, Inc.	105,045	$31,621,696
4	VRTX	Vertex Pharmaceuticals Inc / Ma	49,020	$24,349,704
5	RPRX	Royalty Pharma plc	285,630	$16,015,274
6	EXEL	Exelixis, Inc.	291,162	$15,842,124
7	AXSM	Axsome Therapeutics, Inc.	56,313	$13,783,733
8	ARWR	Arrowhead Pharmaceuticals, Inc.	140,394	$11,443,514

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,255,946	340,365	+0.0%	Shares	Sole	2026-08-05
2026-03-31	$1,184,087	340,255	-15.0%	Shares	Sole	2026-05-05
2025-12-31	$1,388,381	400,110	+19.9%	Shares	Sole	2026-02-06
2025-09-30	$1,849,002	333,755	+1463.0%	Shares	Sole	2025-11-07
2025-06-30	$52,744	21,354	-1.3%	Shares	Sole	2025-08-11
2025-03-31	$43,075	21,646	+0.3%	Shares	Sole	2025-05-13
2024-12-31	$63,042	21,590	-0.4%	Shares	Sole	2025-02-07
2024-09-30	$83,882	21,675	-2.5%	Shares	Sole	2024-11-14
2024-06-30	$114,282	22,234	-0.2%	Shares	Sole	2024-08-13
2024-03-31	$156,002	22,286	+5.5%	Shares	Sole	2024-05-06
2023-12-31	$187,096	21,117	-0.9%	Shares	Sole	2024-02-12
2023-09-30	$203,192	21,299	-0.1%	Shares	Sole	2023-11-08
2023-06-30	$312,367	21,322	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.